Kidephar SRL
The score of Kidephar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -46 % Total assets -38 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Kidephar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −13,992 € | ||||
| Equity | 53,099 € | ||||
| Cash | 21,185 € | ||||
| EBITDA | −11,343 € | ||||
| Total assets | 81,623 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 11 Aug 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
Kidephar's financial analysis
- Solvency65.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Kidephar
Kidephar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0452.044.843
- VAT number
- BE0452044843
- Peppol
- Registered · 0208:0452044843 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Feb 1994
- Registered office
- 6790 Aubange
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Kidephar (SRL) has been based in Aubange since 1994, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 13,992 € and equity of 53,099 €; its revenue is not published. Its solvency stands at 65.1%, above the median of its sector (41.5%).
Companies similar to Kidephar
Companies in the same business, of comparable size and area, outside its group.
- Louis Marquet Retail sale of pharmaceutical products Saint-Georges-sur-Meuse · balance sheet 81,215 €
- Green Cross Solutions Retail sale of pharmaceutical products Aiseau-Presles · balance sheet 82,507 €
- Wardani Retail sale of pharmaceutical products Ganshoren · balance sheet 79,976 €
- ANA-AD Retail sale of pharmaceutical products Oud-Heverlee · balance sheet 83,628 €
- Apotheek Stockman Retail sale of pharmaceutical products Zelzate · balance sheet 79,309 €
- Pharmacie Balza Retail sale of pharmaceutical products Villers-la-Ville · balance sheet 84,172 €
- Van Meirhaeghe Katrien Retail sale of pharmaceutical products Herzele · balance sheet 84,640 €
- Pharmacien Quentin MARCQ Retail sale of pharmaceutical products La Bruyère · balance sheet 84,646 €
Frequently asked questions about Kidephar
What is the revenue of Kidephar?
Kidephar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Kidephar?
In Belgium, the VAT number is the company number prefixed with BE: BE0452044843 for Kidephar, if the company is VAT-registered. Its company number (CBE) is 0452.044.843.
Where is the registered office of Kidephar?
According to the CBE register, the registered office of Kidephar is in 6790 Aubange.
What is the equity of Kidephar?
At the close of the 2025 financial year, the equity of Kidephar amounts to 53,099 €, a solvency of 65.1% of total assets.
Who manages Kidephar?
The register lists 2 active mandates at Kidephar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Kidephar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →